Number of Founded Organizations 1
CB Rank (Person) 514,045
  • Primary Job Title Chairman of the Scientific Advisory Board,Chairman & Founding partner
  • Primary Organization 
    ProQuest Investments Logo
    ProQuest Investments
  • Gender Male

Stuart Holden M.D. has been the Chairman of ProQuest’s Scientific Advisory Board since its founding. Dr. Holden is currently the Director of the Louis Warschaw Prostate Cancer Center at Cedars-Sinai Medical Center. A specialist in urological oncology, Dr. Holden is an attending surgeon at Cedars-Sinai Medical Center and a clinical assistant

professor of Surgery (Urology) at the University of California, Los Angeles. Prior to joining Cedars-Sinai, Dr. Holden was Assistant Professor of Surgery (Urology) at Georgetown University School of Medicine.

Dr. Holden has also served as Medical Director of the Prostate Cancer Foundation (CaP CURE), the world's largest philanthropic source of support for prostate cancer research, since its inception in 1993. He is a member of several professional societies and has been active in organizations such as the American Cancer Society and the Prostate Cancer Research Project for the Department of Defense.

Dr. Holden received his bachelor's degree from the University of Wisconsin-Madison and his medical degree from Cornell University.

Number of Current Jobs 1
Stuart Holden is the Chairman of the Scientific Advisory Board,Chairman & Founding partner at ProQuest Investments.
Number of News Articles 6
NewsApr 20, 2020
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
NewsMar 30, 2020
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
NewsJul 17, 2019
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
NewsJul 18, 2017
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
NewsJun 26, 2017
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
NewsJun 9, 2017
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated